Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

GeoVax Labs Inc

GOVX
Current price
0.4 USD -0.017 USD (-4.00%)
Last closed 0.41 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 11 051 854 USD
Yield for 12 month -50.06 %
Week
Month
Year
GOVX
21.11.2021 - 28.11.2021

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. The company is developing GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine. In addition, it is also developing GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of Zika; GEO-MM02 treatment for malaria; GEO-EM01 for the treatment of fever viruses, such as Ebola, Sudan, and Marburg; GEO-LM01 for the treatment of Lassa fever. GeoVax Labs, Inc. has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; U.S. Department of Defense; Emory University; and the Burnet Institute. GeoVax Labs, Inc. was incorporated in 1988 and is headquartered in Smyrna, Georgia. Address: 1900 Lake Park Drive, Smyrna, GA, United States, 30080

Analytics

WallStreet Target Price

6 USD

P/E ratio

Dividend Yield

2.58 %

Current Year

+81 000 USD

Last Year

+385 000 USD

Current Quarter

Last Quarter

Current Year

+81 000 USD

Last Year

+385 000 USD

Current Quarter

Last Quarter

Key Figures GOVX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -24 370 664 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -55.77 %
PEG Ratio
Return On Equity TTM -116.18 %
Wall Street Target Price 6 USD
Revenue TTM
Book Value 0.34 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -100 %
Dividend Yield 2.58 %
Gross Profit TTM 81 526 USD
Earnings Share -0.89 USD
Diluted Eps TTM -0.89 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics GOVX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History GOVX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield 2.58 %
Last Split Factor 1:20
Payout Ratio
Last Split Date 25.09.2020
Dividend Date 25.09.2020

Stock Valuation GOVX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 10.627
Enterprise Value Revenue 4.1502
Price Sales TTM 59.0082
Enterprise Value EBITDA 0.0759
Price Book MRQ 1.1885

Financials GOVX

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators GOVX

For 52 weeks

0.41 USD 1.39 USD
50 Day MA 0.52 USD
Shares Short Prior Month 836 854
200 Day MA 0.6 USD
Short Ratio 4.48
Shares Short 634 181
Short Percent 2.41 %